Prevalence of anxiety symptoms, depression and temporomandibular dysfunction in prisoners and workers from a brazilian prison: an observational study
José Carlos de Oliveira Gomes Filho, Lucian Lacerda Franco Rocha Rodrigues, Thiago Bezerra Leite, Flávia Dayana Ribeiro da Silveira, Celiane Mary Carneiro Tapety, António Sérgio Guimarães

TL;DR
This study found high rates of anxiety, depression, and jaw-related issues among Brazilian prisoners and prison staff, with prisoners being most affected.
Contribution
The study provides new data on mental health and TMD prevalence in a Brazilian prison population and staff.
Findings
Anxiety and depression levels were 64.86% and 48.64% among prisoners.
Depression influenced jaw symptoms in both employees and prisoners.
Employees with anxiety reported more headaches.
Abstract
Temporomandibular Disorder (TMD) is a condition in which there are several psychosomatic and/or psychosocial aspects. Imprisonment situations may be an example of a triggering factor for stress and TMD symptoms, especially if taken into account that the incarcerated population is bigger than the general population. The present study aims to investigate the prevalence of symptoms of anxiety, depression and temporomandibular disorder (TMD) in prisoners and employees of a closed male penitentiary in Brazil. A total of 140 prisoners and 50 employees were part of the study. This is a cross-sectional study with a quantitative approach, where the symptom questionnaire for Temporomandibular Disorders (DC/TMD) and the Hospital Anxiety and Depression Scale (HAD) were applied. The anxiety and depression levels found in prisoners were 64.86% and 48.64%, respectively. There was a higher…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Anxiety | ||||
|---|---|---|---|---|
|
| ||||
| No | Yes | |||
|
| ||||
| N(%) | N(%) | P-value | OR | |
|
| 0.606 | |||
| No | 14(63.6) | 2(50.0) | ||
| Yes | 8(36.4) | 2(50.0) | ||
|
| 0.030 | |||
| No | 13(59.1) | 0(0.0) | b | |
| Yes | 9(40.9) | 4(100.0) | - | |
|
| 0.090 | |||
| No | 19(86.4) | 2(50.0) | ||
| Yes | 3(13.6) | 2(50.0) | ||
|
| 0.562 | |||
| No | 19(86.4) | 3(75.0) | ||
| Yes | 3(13.6) | 1(25.0) | ||
|
| 0.664 | |||
| No | 21(95.5) | 4(100.0) | ||
| Yes | 1(4.5) | 0(0.0) | ||
| Anxiety | |||
|---|---|---|---|
|
| |||
| No | Yes | ||
|
| |||
| N(%) | N(%) | P-value | |
|
| 0.541 | ||
| No | 10(38.5) | 22(45.8) | |
| Yes | 16(61.5) | 26(54.2) | |
|
| 0.154 | ||
| No | 19(73.1) | 27(56.3) | |
| Yes | 7(26.9) | 21(43.8) | |
|
| 0.838 | ||
| No | 19(/3.1) | 34(70.8) | |
| Yes | 7(26.9) | 14(29.2) | |
|
| 0.208 | ||
| No | 18(69.2) | 26(54.2) | |
| Yes | 8(30.8) | 22(45.8) | |
|
| 0.459 | ||
| No | 26(100.0) | 47(97.9) | |
| Yes | 0(0.0) | 1(2.1) | |
| Depression | ||||
|---|---|---|---|---|
|
| ||||
| No | Yes | |||
|
| ||||
| N(%) | N(%) | P-value | OR | |
|
| 0.286 | |||
| No | 15(65.2) | 1(33.3) | ||
| Yes | 8(34.8) | 2(66.7) | ||
|
| 0.066 | |||
| No | 13(56.5) | 0(0.0) | ||
| Yes | 10(43.5) | 3(100.0) | ||
|
| 0.369 | |||
| No | 18(78.3) | 3(100.0) | ||
| Yes | 5(21.7) | 0(0.0) | ||
|
|
| |||
| No | 21(91.3) | 1(33.3) | b | |
| Yes | 2(8.7) | 2(66.7) | 21,000(1,271-346.934) | |
|
| 0.713 | |||
| No | 22(95.7) | 3(100.0) | ||
| Yes | 1(4.3) | 0(0.0) | ||
| Depression | ||||
|---|---|---|---|---|
|
| ||||
| No | Yes | |||
|
| ||||
| N(%) | N(%) | P-value | OR | |
|
| 0.790 | |||
| No | 17(44.7) | 15(41.7) | ||
| Yes | 21(55.3) | 21(58.3) | ||
|
| 0.254 | |||
| No | 26(68.4) | 20(55.6) | ||
| Yes | 12(31.6) | 16(44.4) | ||
|
| 0.686 | |||
| No | 28(73.7) | 25(69.4) | ||
| Yes | 10(26.3) | 11(30.6) | ||
|
|
| |||
| No | 28(73.7) | 16(44.4) | b | |
| Yes | 10(26.3) | 20(55.6) | 3,500(1,318-9,293) | |
|
| 0.301 | |||
| No | 38(100.0) | 35(97.2) | ||
| Yes | 0(0.0) | 1(2.8) | ||
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTemporomandibular Joint Disorders · Occupational health in dentistry · Musicians’ Health and Performance
Introduction
Temporomandibular disorder (TMD) is a complex condition within a biopsychosocial disease model, and which, in most cases, is not a pathology only located in the orofacial region (Ohrbach, Dworkin, 2016). TMD symptoms include decreased range of mandibular movement, functional limitation of the mandible, pain in the orofacial muscles, and in the temporomandibular joint (TMJ), noises or deviation during mouth opening (Liu, Steinkeler, 2013). TMD is one of the most common chronic musculoskeletal diseases. Due to its relation to pain, it can disturb the daily activities of the affected individual, as well as their psychosocial functioning and their quality of life. For this very reason, it is important to accurately diagnose this condition so that clinical care is carried out (Ahmad, Schiffman, 2016; Bitiniene et al., 2018). This condition may be caused by muscle hyperfunction or parafunction, traumatic injuries, hormonal influences, and joint changes (Liu, Steinkeler, 2013). Some studies also associate TMD with anxiety, stress and depression (Nazeri et al., 2018; Sójka et al., 2019). Some studies also associate TMD with anxiety, stress and depression (Nazeri et al., 2018; Sójka et al., 2019). In order to identify symptoms and diagnosis, the DC/TMD protocol (Diagnostic Criteria for Temporomandibular Disorders) is the only evidence-based TMD diagnostic system that has undergone rigorous scientific investigation. Its use, both in clinical settings and in scientific research, allows the standardization of criteria for decision-making diagnoses and the identification of patients with a variety of TMD presentations, from simple to more complex cases (Schiffman et al., 2014; Ohrbach, Dworkin, 2016). This protocol was validated for the Portuguese language in 2016 (Ohrbach, 2016).
Incarcerated individuals often experience psychological distress, such as anxiety and depression, and there is a lack of interventions to deal with this situation (López-Pérez et al., 2018). The prevalence of self-reported TMD symptoms and diagnosed TMD symptoms has been considered high in prisoners (Vainionpää et al., 2018).
In this context, considering that prisons are stressful environments, for both prisoners and workers, given the scarcity of work with the incarcerated population, this study aims to assess the prevalence of TMD symptoms, as well as depression and anxiety among inmates and employees of a closed male penitentiary located in Brazil.
Materials and methods
Type of study
This work is a cross-sectional, descriptive-exploratory study, with a quantitative approach that followed the STROBE checklist.
Ethical aspects
The study was carried out following the ethical resolutions, respecting the principles of beneficence, non-maleficence, autonomy and justice. It was approved by the Ethics and Research Committee of Sào Leopoldo Mandic College (Campinas, Brazil) under protocol number: 5.257.823.
Research location and Study population
For the study, individuals under deprivation of liberty in a Brazilian penitentiary (Bom Jesus, PI, Brazil) were evaluated. The sample calculation for a finite population was used, stratified by proportion. The population consisted of 140 prisoners and 50 employees, with a sampling error of 5% and a confidence level of 95%. Prisoners with more than six months of imprisonment who voluntarily agreed to participate in the study and answer the questionnaires were included. Prisoners with general inflammatory diseases of the connective tissue (e.g. rheumatoid arthritis) and prisoners with symptoms that could be attributed to other diseases of the orofacial region (e.g. toothache, neuralgia) were not included in the sample.
Those who refused to answer the questions or sign the Informed Consent Form (ICF) were excluded. In order to make comparisons, data was collected with people who work in the same prison too.
Data collection
The application of the DC/TMD and of the Hospital Anxiety and Depression (HAD) questionnaires was done by signing the ICF at the place and time authorized by the penitentiary board, respecting the local prison safety rules and COVID-19 prevention rules, such as the use of PFF2 masks without valve and sanitize hands with alcohol gel, as well as clipboards and pens with 70% liquid alcohol. Two questionnaires were applied: the first was the Temporomandibular Disorders Symptoms Questionnaire translated into Portuguese (Ohrbach, 2016). This questionnaire consists of 17 questions that assess the presence of jaw pain, history of jaw locks with the mouth open or closed, and the presence of joint noises. In this questionnaire, five points are decisive in the diagnosis of TMD: orofacial pain, headache that extends to the temples, joint sounds, closed mandibular locking and open mandibular locking. The second was the HAD Anxiety and Depression Scale translated into Portuguese (Botega et al., 1995). It consists of 14 questions that assess symptoms of anxiety and depression and it has an evaluation score: Anxiety (Without anxiety from 0 to 8 and With anxiety ≥ 9) and Depression (Without depression from 0 to 8 and with depression ≥ 9).
Statistical analysis
Descriptive analyses were performed to verify data consistency. For qualitative variables (categorical), absolute and relative frequency was used. For quantitative (numerical), data, position (mean) and dispersion (standard deviation) measures were used. The data were entered into an electronic spreadsheet in the Microsoft Excel® editor and analyzed using the software Statistical Package for the Social Sciences, version 26. In this work, the usual confidence level of 5% (0.05) was used, in order to perform analysis of the statistical tests, and p-value<0.05 was considered significant, thus, the hypothesis of equality (Ho) was disregarded.
Results
The total sample consisted of 100 individuals (74% of prisoners and 26% of prison employees) divided into two research groups. The results of the assessment of the HAD scale showed that 15.4% of the employees had anxiety symptoms, while the anxiety rate in prisoners was 64.9%. Regarding depression, the percentage of employees with symptoms was only 11.5%, while the number of prisoners with depression reached 48.6%. Table 1 shows the association between anxiety symptoms and TMD only among prison employees. No statistical significance was found between the results, except for the question about headaches extending to the temples, as 100% of the employees who reported anxiety also complained of headaches in the temporal region.
When analyzing the association between symptoms of anxiety and TMD only in the arrested individuals, no statistical significance was found (Table 2). When performing the same analysis of association between depression and TMD with prison employees, it was only possible to observe statistical significance in relation to closed locking. Those who had symptoms of depression were 21 times more likely to have symptoms of mandibular closed locking (Table 3). When evaluating the association between depression and TMD with prisoners, statistical significance was also observed only regarding closed locking. Prisoners who have symptoms of depression were 3.5 times more likely to have symptoms of mandibular locking (Table 4).
Discussion
In the present study, TMD symptoms were evaluated in both prisoners and employees, and the results could be compared. The TMD symptoms most found in prison workers were: headache extending to the temporal region (50%), orofacial pain (38.5%), and joint noises (19.2%). These findings are similar to others TMD symptoms related in prisoners in other studies (Enguelberg-Gabbay et al., 2016; Vainionpää et al., 2018). Several studies have evaluated the prevalence of depression and anxiety in prisoners from different countries around the world: Turkey (Unver et al., 2013), Italy (Cavallo et al., 2014; D'aurizio et al., 2020), Nigeria (Osasona, Koleoso, 2015), England (López-Pérez et al., 2018; Packham et al., 2020; Butcher et al., 2021), Scotland (Arora et al., 2020), Brazil (Ranuzi et al., 2020), Poland (Stawinska-Witoszynska et al., 2021), and Ethiopia (Abdulkadir et al., 2022). None of these researchers investigated symptoms of anxiety and depression in professionals working in the same penitentiaries, c ontrary to this present study, in which it was observed that 15.4 % of employees had symptoms of anxiety and 11.5 % had symptoms of depression. Different types of questionnaires were used to investigate the presence of anxiety and depression with different parameters: DASS-42 (Unver et al., 2013), EQ-5D (Cavallo et al., 2014), HAD (Osasona, Koleoso, 2015), CES-D (López-Pérez et al., 2018; Arora et al., 2020), GAD-7 (López-Pérez et al., 2018; Packham et al.; 2020; Butcher et al., 2021), PHQ -9 (Packham et al., 2020; Butcher et al., 2021; Abdulkadir et al., 2022), BDI-2 (D'aurizio et al., 2020), STAI (D'aurizio et al., 2020), and DASS-21 (Ranuzi et al., 2020). One of the studies investigated more comprehensively the anxiety and depression symptoms of prisoners through their prison medical records, pre-incarceration medical records, the results of medical consultations outside prison, and the results of complementary tests (Stawinska-Witoszynska et al., 2021). The HAD scale was chosen to be used in the present study because it is a short questionnaire, which can be filled in just a few minutes, used in non-psychiatric environments, it is easy to understand, and the answers are based on how the individual felt during the previous week. It is possible to notice that the mentioned literature is limited. The reason behind this is that usually research in prisons are rare due to bureaucracy, but also to the great possibility of encountering various obstacles during the process, such as violence (Unver et al., 2013; Cavallo et al., 2014; Osasona, Koleoso, 2015; Enguelberg-Gabbay et al., 2016; López-Pérez et al., 2018; Vainionpää et al., 2018; Arora et al., 2020; D'aurizio et al., 2020; Packham et al., 2020; Butcher et al., 2021; Stawinska-Witoszynska et al., 2021; Abdulkadir et al., 2022).
The number of prisoners with anxiety, according to the HAD scale, was considered high in this study (64.9%). Other studies showed different results: 61.9% (Unver et al., 2013), 77.8% (Osasona, Koleoso 2015), 59.1% (López-Pérez et al., 2018), 31.5% (Packham et al., 2020), 49.4% (Butcher et al., 2021) and 6.9% (Stawinska-Witoszynska et al., 2021). Regarding depression, according to the HAD scale, in this study it was found that 48.6% of the prisoners had depressive symptoms. The referenced literature indicates a variation between 1.7 and 72.6% (Unver et al., 2013; Osasona, Koleoso 2015; López-Pérez et al., 2018; Arora et al., 2020; Packham et al., 2020; Ranuzi et al., 2020; Butcher et al., 2021; Stawinska-Witoszynska et al., 2021; Abdulkadir et al., 2022). Anxiety and depression levels were also assessed in prison workers with results of 15.38% and 11.53%, respectively. Counterweighting the levels found in prisoners of the same prison, 64.86% for anxiety and 48.64% for depression, the levels of the workers are significantly lower. This shows that the prison environment affects the prisoners' mental health much more than the employees' mental health. The present study observed important values in the number of prisoners with symptoms of orofacial pain (56.75%), headaches that includes the temporal region (37.83%), joint noises (28.37%), and jaw locking (40.54%). Only in the open locking of the mandible item, the rate was low (1.35%). In Finland, a study using the same questionnaire had similar results in terms of orofacial pain (54%) and headache that includes the temporal region (37%), with much higher results in terms of joint noise (43%) and open locking of the mandible (8%), and a much lower value when referring to closed mandibular locking, with only 7% (Vainionpää et al., 2018). Another study showed that 46.3% of drug-using prisoners had TMD symptoms, while the result among non-drug users was only 25.6% (Enguelberg-Gabbay et al., 2016). Although the results are close to those found in the present study, it did not distinguish between drug users and non-users. Further conclusions come up against the limitations of the present study, which is a preliminary analysis of a sample. Access to medical records of prisoners prior to imprisonment, if they exist, could show us whether symptoms of anxiety, depression, and TMD were already present. There are few studies that have evaluated symptoms of anxiety and depression in prisoners in Brazil, and the results can be worrying, which indicates the need for further studies in prisons in different locations.
Conclusion
It can be concluded that prison life affects prisoners and staff differently with regard to anxiety, depression, and TMD. It is clear that prisoners suffer much more from anxiety and depression than employees of the same prison.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Abdulkadir H Girma M Gebru Z Sidamo NB Temesgen G Magnitude of Depression and Its Associated Factors Among Prisoners in Arba Minch and Jinka Town, Southern Ethiopia Psychol. Res. Behav. Manag 2022156150515163572622310.2147/PRBM.S 362303 PMC 9206451 · doi ↗ · pubmed ↗
- 2Ahmad M Schiffman EL Temporomandibular Joint Disorders and Orofacial Pain Dent Clin North Am 20166011051242661495110.1016/j.cden.2015.08.004PMC 6762033 · doi ↗ · pubmed ↗
- 3Arora G Humphris G Lahti S Richards D Freeman R Depression, drugs and dental anxiety in prisons: A mediation model explaining dental decay experience Community Dent. Oral Epidemiol 20204832482553204328410.1111/cdoe.12522 · doi ↗ · pubmed ↗
- 4Bitiniene D Zamaliauskiene R Kubilius R Leketas M Gailius T Smirnovaite K Quality of life in patients with temporomandibular disorders. A systematic review Stomatol. Balt. Dent. Maxillofac. J 20182013929806652 · pubmed ↗
- 5Botega NJ Bio MR Zomignani MA Garcia C Jr Pereira WAB Transtornos do humor em enfermaria de clinica médica e validação de escala de medida (HAD) de ansiedade e depressão Rev. Saude Publica 199529535936310.1590/s 0034-891019950005000048731275 · doi ↗ · pubmed ↗
- 6Butcher E Packham C Williams M Miksza J Kaul A Khunti K Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold. BMC Psychiatry BMC Psychiatry 20212111113449680610.1186/s 12888-021-03453-2PMC 8428050 · doi ↗ · pubmed ↗
- 7Cavallo P Savarese G Carpinelli L Bruxism and health related quality of life in Southern Italy's prison inmates Community Dent. Health 201431211712225055610 · pubmed ↗
- 8D'aurizio G Caldarola A Ninniri M Avvantaggiato M Curcio G Sleep quality and psychological status in a group of italian prisoners Int. J. Environ. Res. Public Health 2020171211010.3390/ijerph 17124224 PMC 734484532545743 · doi ↗ · pubmed ↗
